Company
Who we are
We’re on a mission to improve and extend lives by learning from the experience of every person with cancer.
![Flatiron_Website_02022023-82 Flatiron_Website_02022023-82](https://flatiron.com/hs-fs/hubfs/_2023Redesign/Photos%20Square/Flatiron_Website_02022023-82.jpg?width=560&height=560&name=Flatiron_Website_02022023-82.jpg)
What we do
At FLATIRON HEALTH®, we believe learning from the experience of every person with cancer is an imperative—it is the key to accelerating research and continuing to improve the quality of care.
Our vision is to build a world where technology and science close the gap between care and research.
![data-for-good-flatiron-video](https://flatiron.com/hubfs/data-for-good-flatiron-video.jpg)
![Flatiron_Website_02022023-99 Flatiron_Website_02022023-99](https://flatiron.com/hubfs/_2023Redesign/Photos%20Square/Flatiron_Website_02022023-99.jpg)
Our story
FLATIRON HEALTH® is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every person’s story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world.
Founded in 2012, Flatiron became an independent affiliate of the Roche Group in 2018. Under the new leadership of CEO Carolyn Starrett in 2021, we’ve expanded our commitment to advance research and treatment for patients around the globe. Flatiron International subsidiaries in Japan, Germany and the United Kingdom will partner with hospitals and health networks in collaborations tailored to each market’s needs and legal, regulatory and compliance requirements.
Our team
We’re a diverse group of passionate, curious individuals from a wide range of backgrounds, working together to solve problems that matter.
Nick Accomando
Chief Risk & Compliance Officer
Rory Brecker
General Counsel
Allison Candido
Vice President & Head of Engineering
Alex Deyle
General Manager, Clinical Research
Bruce Gottlieb
Chief Operating Officer
Nathan Hubbard
Chief Business Officer
Jonathan Kish
Vice President & Head of Research Sciences
Jaime Lopez
Chief Design & Marketing Officer
Neal Meropol, MD
Vice President, Research Oncology
Julia Morton
Senior Vice President & General Manager, Flatiron HC
Stephanie Reisinger
Senior Vice President & General Manager, Real-World Evidence
Will Shapiro
Chief of AI & Vice President, Data Science
Carolyn Starrett
Chief Executive Officer
Ara Tucker
Chief People Officer
We embody our values
Solve problems that matter
Identify and solve problems that drive our mission forward. Prioritize rigorously by focusing on work that moves the needle for our customers and patients.
Our commitment to diversity, equity, and inclusion
We strive to create an environment where varied perspectives work together to transform cancer care. We believe in elevating voices, celebrating differences, and cultivating belonging.
![DEI DEI](https://flatiron.com/hubfs/Flatiron%20Logos/DEI.jpg)
![end-cancer end-cancer](https://flatiron.com/hs-fs/hubfs/_2023Redesign/End%20Cancer/end-cancer.jpg?width=1200&height=1200&name=end-cancer.jpg)
Be the next changemaker in cancer care
Reimagine the infrastructure of cancer care within a technology and science community that values integrity, inspires growth, and is uniquely positioned to create a more modern, connected oncology ecosystem.
Our commitment to data confidentiality
Flatiron has established and maintains robust standards for the communication and protection of confidential information.
Transforming global oncology research and care
We’re accelerating cancer research and improving the quality of care globally, using real-world evidence to improve patient outcomes, inform policy, and advance research